PDCD1 and neoplasm: In the group treated with anti-PD-1 alone, 4 out of 11 mice were tumor-free, whereas, in the group treated with both anti-PD-1 and tier 1 neoantigen vaccination, 10 out of 11 mice were tumor-free (Fig. 4e).